Percutaneous permeation and skin irritation of JP-8+100 jet fuel in a porcine model.

JP-8 is the major jet fuel used by US Air Force. JP-8+100 is a new jet fuel recently introduced by the US Air Force, which contains JP-8 plus three performance additives [butylated hydroxytoluene (BHT), metal deactivator (MDA) and 8Q405]. The purpose of the present study was to investigate the percutaneous permeation of JP-8+100 across pig ear skin in vitro and to study the effect of JP-8+100 exposure on the skin barrier function, moisture content and irritation in Yucatan minipigs. The influence of performance additives on the permeation of JP-8 was studied by adding each additive individually to JP-8. The percutaneous permeation and skin irritation data obtained with JP-8+100 were compared with that of JP-8. JP-8+100 spiked with 5.0 microCi of radiolabeled [14C]tridecane, nonane, naphthalene or toluene (selected components of JP-8+100) was used for the in vitro percutaneous permeation studies. For skin irritation studies, 250 microl of JP-8+100 was placed in a Hill top chamber and affixed over the marked treatment area for 24 h. The components of JP-8+100 such as tridecane, nonane, naphthalene and toluene permeated readily through pig ear skin without any apparent lag time. Compared to JP-8, the permeation of tridecane, toluene and nonane from JP-8+100 was significantly lower (P<0.05). However, the permeation of naphthalene from JP-8+100 was significantly higher than from JP-8. When BHT was added to JP-8, the permeation of all four chemicals were significantly decreased (P<0.05). Though the addition of 8Q405 to JP-8 decreased the permeation of all four chemicals, the values were not significantly different (P>0.05) from that of JP-8. Addition of MDA did not show any significant change in the permeation of the selected chemicals from JP-8. Application of JP-8+100 increased the transepidermal water loss (TEWL) about three times compared to the baseline level. The skin moisture content decreased consistently after the application of JP-8+100, though it was not significantly different (P>0.05) from the baseline level. JP-8+100 caused a moderate erythema (score: 1.60) and a moderate to severe edema (score: 2.60). These results suggest that JP-8+100 produces significant changes in the barrier function of the skin and a local irritant effect upon occlusive dermal exposure. However there was no significant difference in the skin irritation data observed from JP-8 and JP-8+100.